GPR119 rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human GPR119 |
GPR119 rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human GPR119 |
Rabbit polyclonal anti-GPR119 antibody
Applications | IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized peptide derived from internal of human GPR119. |
Goat Polyclonal Antibody against GPR119
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Peptide with sequence SARNCGPERPRESS, from the C Terminus (near) of the protein sequence according to NP_848566.1. |
Rabbit anti GPCR119 Polyclonal Antibody
Applications | WB |
Reactivities | Mouse |
Conjugation | Unconjugated |
Immunogen | A synthetic peptide corresponding to the extracellular domain of mouse GPR 119 protein. This sequence is identical to rat. |
GPR119 rabbit polyclonal antibody
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide of human GPR119 |
GPR119 Rabbit polyclonal Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Recombinant protein of human GPR119. |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
Applications | Bl, ELISA, IF |
Reactivities | Human, Mouse, Rat, Dog |
Conjugation | Unconjugated |
Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
Applications | Bl, ELISA, IF |
Reactivities | Human, Mouse, Rat, Dog |
Conjugation | Unconjugated |
Modifications | This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |